The role of CXCL10 in prognosis of patients with colon cancer and tumor microenvironment remodeling

Abstract

We discovered that CXCL10 levels could be effective for predicting the prognosis of COAD patients as well as a clue that the status of TME is transitioning from immunological to metabolic activity, which provided additional information for COAD therapies.